Therapeutics sector crushes Q1 expectations with 14.5% revenue beats and a 10% average stock surge—Moderna dominates with a 260% revenue jump and two new European approvals, while Novavax surprises with an 84.5% earnings beat despite a 79% revenue drop, and United Therapeutics stumbles with a 1.6% revenue decline and miss, reminding us that even in a booming industry, every company’s path is unique.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
